Position in PFE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$307,718
-$51,116 QoQ
Shares Held
12,779
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#2,114
of 2,826 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DT Investment Partners, LLC holds $27,488,762 across 12 Drug Manufacturers - General names. PFE ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
55,162 | $14,009,493 | |
| 2 | ABBV |
AbbVie Inc.
|
25,006 | $6,292,509 | |
| 3 | MRK |
Merck & Co., Inc.
|
30,995 | $3,982,857 | |
| 4 | LLY |
ELI LILLY & Co
|
1,645 | $1,973,062 | |
| 5 | AMGN |
Amgen Inc
|
1,181 | $427,663 | |
| 6 | PFE |
Pfizer Inc
This page
|
12,779 | $307,718 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,180 | $275,421 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,383 | $137,308 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $307,718 | 12,779 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $358,834 | 12,779 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $327,908 | 13,169 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $434,968 | 17,071 | Shares | Other | 2025-10-22 | |
| 2025-06-30 | $1,062,511 | 43,833 | Shares | Other | 2025-07-22 | |
| 2025-03-31 | $1,118,253 | 44,130 | Shares | Other | 2025-04-29 | |
| 2024-12-31 | $1,387,120 | 52,285 | Shares | Other | 2025-01-30 | |
| 2024-09-30 | $1,625,703 | 56,175 | Shares | Other | 2024-10-23 | |
| 2024-06-30 | $1,562,374 | 55,839 | Shares | Other | 2024-07-24 | |
| 2024-03-31 | $1,501,996 | 54,126 | Shares | Other | 2024-05-13 | |
| 2023-12-31 | $1,352,927 | 46,993 | Shares | Other | 2024-01-31 | |
| 2023-09-30 | $1,589,937 | 47,933 | Shares | Other | 2023-10-27 | |
| 2023-06-30 | $1,667,582 | 45,463 | Shares | Other | 2023-08-28 | |
| 2023-03-31 | $1,853,870 | 45,438 | Shares | Other | 2023-05-03 | |
| 2022-12-31 | $2,216,078 | 43,249 | Shares | Other | 2023-01-31 | |
| 2022-09-30 | $1,656,140 | 37,846 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $2,260,361 | 43,112 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $1,871,795 | 36,156 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,814,192 | 30,723 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,498,640 | 34,844 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $958,127 | 24,467 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $815,392 | 22,506 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $695,082 | 18,883 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $985,063 | 26,841 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $964,258 | 29,488 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $726,010 | 22,243 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||